Advisory Committee On Dextromethorphan Raises Stakes On Age Restriction
Executive Summary
The Drug Safety and Risk Management Advisory Committee meeting scheduled for Sept. 14 on the potential for abuse of the cough suppressant dextromethorphan could bring the OTC industry's next regulatory nightmare